Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 26 citing Broder: Antiretroviral therapy in AIDS. (0.10 sec) 

Two-drug combinations of zidovudine, didanosine, and recombinant interferon-α A …


VA Johnson, DP Merrill, JA Videler, TC Chou, RE … - The Journal of infectious …, 1991 - jstor.org
Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant ... Interferon-a A Inhibit
Replication of Zidovudine-Resistant Human ... Victoria A. Johnson, Debra P. Merrill, Joseph
A. Videler, Ting-Chao Chou, Roy E. Byington, Joseph J. Eron, Richard T. D'Aquila, and ...
Cited by 95 - Related articles - All 4 versions

[PDF] Perspectivesin CancerResearch Acquired Immunodeficiency Syndrome and Non- …


JE Karp, S Broder - Cancer Research, 1991 - AACR
Even before AIDS, NHL have been a growing problem. The incidence of non-Hodgkin's lymphoma
in both men and women in the United States and in other countries has been steadily rising over
the last 20 years and is still largely unexplained. This increase in NHL has not been ...
Cited by 60 - Related articles - All 3 versions

Antiretroviral therapy: strategies beyond single-agent reverse transcriptase …

- nih.gov [PDF] 
KJ Connolly, SM Hammer - Antimicrob Agents Chemother, 1992 - Am Soc Microbiol
Page 1. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 1992, p. 509-520 Vol. 36,
No. 3 0066-4804/92/030509-12$02.00/0 Copyright X 1992, American Society for Microbiology
MINIREVIEW Antiretroviral Therapy: Strategies beyond Single-Agent ...
Cited by 52 - Related articles - All 13 versions

Drug interactions with zidovudine


DM Burger, PL Meenhorst, CHW Koks, JH Beijnen - AIDS, 1993 - journals.lww.com
446 AIDS 1993, Vol 7 No 4 excretion accounts for 25%. Ten to thirty per cent of the administered
dose is excreted unchanged in the urine as a result of glomerular filtration and ac- tive tubular
secretion. The remainder is metabolized in the liver to 5'-glucuronyl 2DV (GZDV) and ...
Cited by 32 - Related articles - BL Direct - All 4 versions

The pancreas in AIDS


MS Cappell - Gastroenterology Clinics of North America, 1997 - Elsevier
Patients with the acquired immunodeficiency syndrome (AIDS) are subject to the same pancreatic
diseases affecting the general population. In particular, patients who develop AIDS from intravenous
drug abuse have an increased incidence of alcoholism and consequently may suffer from ...
Cited by 20 - Related articles - BL Direct - All 9 versions

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in …

- nih.gov [PDF] 
M Barry, JL Howe, S Ormesher, DJ Back, … - British journal of …, 1994 - pubmedcentral.nih.gov
1 Zidovudine (ZDV) has proved unsuccessful in controlling disease progression over extended
periods of time in patients with AIDS. Combination of ZDV with another reverse transcriptase
inhibitor, dideoxyinosine (ddl) may improve the duration of effectiveness of antiretroviral ...
Cited by 16 - Related articles - BL Direct - All 4 versions

Keto/enol epoxy steroids as HIV-1 Tat inhibitors: Structure-activity relationships and …


WF Michne, JD Schroeder, TR Bailey, HC … - Journal of Medicinal …, 1995 - pubs.acs.org
Inhibition of the HIV-1 nuclear regulatory protein tat could potentially yield particularly useful
drugs because it functions as an activator of transcription. It has no known cellular
counterpart, and deletions in the tat gene destroy the ability of HIV-1 to replicate. We ...
Cited by 14 - Related articles - BL Direct - All 3 versions

New approaches to the treatment of chronic viral hepatitis B and C


F Regenstein - The American journal of medicine, 1994 - Elsevier
Interferon treatment of hepatitis B and C virus (HBV, HCV) infections has been hampered by
overall initial response rates of <50%, a relapse rate that is >50% for patients with chronic
HCV, and rare responses in individuals with chronic HBV who are immunosuppressed or ...
Cited by 12 - Related articles - BL Direct - All 4 versions

Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and …

- nih.gov [PDF] 
ME Hawkins, H Mitsuya, CM McCully, KS … - Antimicrobial agents …, 1995 - aac.highwire.org
Page 1. A NTIMICROBIAL A GENTS AND C HEMOTHERAPY , June 1995, p. 1259–1264
Vol. 39, No. 6 0066-4804/95/$04.00 0 Copyright 1995, American Society for Microbiology
Pharmacokinetics of Dideoxypurine Nucleoside Analogs in ...
Cited by 10 - Related articles - BL Direct - All 6 versions

Preparation of nucleoside-LDL-conjugates for the study of cell-selective …


HW Schultis, H Baeyer, H Neitzel, E … - Clinical Chemistry and …, 1991 - reference-global.com
Schultis et al.: LDL äs targetable drug carrier ... Eur. J. Clin. Chem. Clin. Biochem. Vol. 29,
1991, pp. 665-674 Đ 1991 Walter de Gruyter & Co. Berlin · New York ... By H.-W. Schultis1'*,
H. v. Baeyer2, Heidemarie Neitzel3 and E. Riedel· ... 1 Institut für Biochemie, Freie ...
Cited by 7 - Related articles - All 3 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google